Akcea Therapeutics Stock Price To Earning
Akcea Therapeutics fundamentals help investors to digest information that contributes to Akcea Therapeutics' financial success or failures. It also enables traders to predict the movement of Akcea Stock. The fundamental analysis module provides a way to measure Akcea Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akcea Therapeutics stock.
Akcea |
Akcea Therapeutics Company Price To Earning Analysis
Akcea Therapeutics' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Akcea Therapeutics Price To Earning | (10.02) X |
Most of Akcea Therapeutics' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akcea Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Akcea Therapeutics has a Price To Earning of -10.0211 times. This is 138.78% lower than that of the Healthcare sector and notably lower than that of the Biotechnology industry. The price to earning for all United States stocks is 134.89% higher than that of the company.
Akcea Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akcea Therapeutics' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akcea Therapeutics could also be used in its relative valuation, which is a method of valuing Akcea Therapeutics by comparing valuation metrics of similar companies.Akcea Therapeutics is currently under evaluation in price to earning category among related companies.
Akcea Fundamentals
| Return On Equity | -9.8 | |||
| Return On Asset | -5.95 | |||
| Profit Margin | (12.34) % | |||
| Operating Margin | (13.60) % | |||
| Current Valuation | 1.47 B | |||
| Shares Outstanding | 101.61 M | |||
| Shares Owned By Insiders | 82.88 % | |||
| Shares Owned By Institutions | 20.84 % | |||
| Number Of Shares Shorted | 1.17 M | |||
| Price To Earning | (10.02) X | |||
| Price To Book | 3.85 X | |||
| Price To Sales | 5.49 X | |||
| Revenue | 336.56 M | |||
| Gross Profit | 185.72 M | |||
| EBITDA | (39.09 M) | |||
| Net Income | (55.01 M) | |||
| Cash And Equivalents | 389.89 M | |||
| Cash Per Share | 3.84 X | |||
| Total Debt | 14.76 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 12.17 X | |||
| Book Value Per Share | 4.72 X | |||
| Cash Flow From Operations | 96.47 M | |||
| Short Ratio | 1.35 X | |||
| Earnings Per Share | (0.56) X | |||
| Price To Earnings To Growth | (0.11) X | |||
| Number Of Employees | 294 | |||
| Beta | 1.44 | |||
| Market Capitalization | 1.85 B | |||
| Total Asset | 175.83 M | |||
| Retained Earnings | (519.26 M) | |||
| Working Capital | 119.04 M | |||
| Current Asset | 174.18 M | |||
| Current Liabilities | 55.15 M | |||
| Z Score | 73.2 |
Pair Trading with Akcea Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akcea Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akcea Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Texas Instruments could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Texas Instruments when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Texas Instruments - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Texas Instruments Incorporated to buy it.
The correlation of Texas Instruments is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Texas Instruments moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Texas Instruments moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Texas Instruments can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Akcea Therapeutics information on this page should be used as a complementary analysis to other Akcea Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Akcea Stock
If you are still planning to invest in Akcea Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akcea Therapeutics' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |